The FDA is responsible for ensuring the safety and efficacy of products that incorporate nanotechnology. This includes evaluating the potential risks and benefits associated with nanomaterials used in food, drugs, cosmetics, and medical devices. Given the novel properties of nanomaterials, traditional assessment methods may not be sufficient, necessitating specialized evaluations.
